Drug Database
Back to search

Switzerland· 62986001

Velphoro, Kautabletten

A sucroferric oxyhydroxide product containing ferrum, registered in Switzerland by Vifor Fresenius Medical Care Renal Pharma Ltd. and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC V03AE05

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVelphoro, KautablettenATCV03AE05REGISTER NO.62986001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ferrumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sucroferric oxyhydroxide is registered in 12 of 19 countries.

Countries holding a registration under ATC V03AE05 (sucroferric oxyhydroxide), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose
Search sucroferric oxyhydroxide products by name

Sucroferric oxyhydroxide · ATC V03AE05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sucroferric oxyhydroxide costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • Switzerland: $1.80 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sucroferric oxyhydroxide · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.80
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
ferrum
Manufacturer
Vifor Fresenius Medical Care Renal Pharma Ltd.
Country
Switzerland (CH)
ATC code
V03AE05
ATC class
Sucroferric oxyhydroxide
Defined daily dose
1.5 g, O
Swissmedic category
B
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680629860013
    90 Stk
    CHF 224.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sucroferric oxyhydroxide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sucroferric oxyhydroxide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Belgium · Tardyneo, Tardysol
  • Bulgaria · Малтофер
  • Czechia · Ferric Carboxymaltose Teva
  • Germany · Carbofeo, Eisencarboxymaltose Al
  • Denmark · Feriliva, Ferofix
  • Estonia · Ferrum, Ferrum Lek
  • Spain · Carboximaltosa Férrica Teva
  • France · Carboxymaltose Ferrique Teva, Tardyferon Enfants Et Adultes
  • United Kingdom (Northern Ireland) · Galfer, Molcava
  • Greece · Ferric Carboxymaltose Teva, Tardy-Fer
  • Croatia · Ferrum, Friona Teva
  • Hungary · Vas (Iii)-Karboximaltóz
  • Ireland · Galfer
  • Italy · Carbossimaltosio Ferrico Mylan, Carbossimaltosio Ferrico Teva
  • Lithuania · Ferrum Lek, Tardyliq
  • Luxembourg · Tardyneo, Tardysol
  • Latvia · Ferrum Lek, Tardyliq
  • Malta · Ferrovin, Galfer
  • Netherlands · Ferrofumaraat Cf, Hemafer
  • Norway · Feriliva
  • Poland · Ferrum Lek, Tardysol
  • Portugal · Carboximaltose Férrica Teva
  • Romania · Carboximaltoză Ferică Teva
  • Sweden · Feriliva, Ferofix
  • Slovenia · Ferrum Lek, Friona
  • Slovakia · Ferric Carboxymaltose Teva, Hemafer

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6d46774b-a97c-4327-b2be-48bfbcd11487
GET /v1/drugs/6d46774b-a97c-4327-b2be-48bfbcd11487?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "ferri oxyhydroxidum/saccharum/amyla 2500 mg",
  "valid_from": "2015-03-01",
  "limitations": "[{\"description\":\"Unmöglichkeit, ein Kalzium-Phosphatprodukt von 4.4 oder weniger mit einem Chelatbildner auf Kalzium-Basis, welcher nicht mehr als 1,5 g elementares Kalzium enthält, zu erreichen.\",\"costApproval\":null,\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2015-03-01\"}]",
  "galenic_form": "Kautabl 500 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2015-03-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about sucroferric oxyhydroxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console